Related Experiment Video
Updated: Jun 12, 2026
10:34
Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Molecular and Pathophysiological Mechanisms Underlying Chronic Subdural Hematoma Recurrence: A Comprehensive Review.
Pratham B Bhatt1, Jason Luo1, Emmanuel O Mensah1
1Neurosurgical Service, Beth Israel Deaconess Medical Center and Harvard Medical School, 110 Francis Street, Boston, MA, 02215, USA.
Neuromolecular Medicine
|June 10, 2026
Summary
Chronic subdural hematoma (cSDH) recurrence stems from unresolved inflammation and abnormal blood vessel growth within the brain's membranes. New therapies target these biological factors to improve treatment outcomes.
Area of Science:
- Neuroscience
- Inflammation Biology
- Vascular Biology
Background:
- Chronic subdural hematoma (cSDH) is increasingly recognized as an active inflammatory process, not just trauma-related.
- Recurrence rates after treatment reach up to 30%, highlighting significant challenges in management.
Purpose of the Study:
- To review molecular, histopathological, biochemical, and radiographic factors associated with cSDH activity and recurrence.
- To understand the interplay of inflammation, angiogenesis, and fibrinolysis in cSDH persistence.
Main Methods:
- Comprehensive narrative review of existing literature.
- Focus on inflammatory mediators, immune cells, angiogenic pathways, and fibrinolytic system.
- Analysis of structural membrane remodeling and systemic factors.
Main Results:
- Recurrent cSDH features a pro-inflammatory, pro-angiogenic microenvironment with elevated interleukins (IL-6, IL-8) and M1/M2 macrophage imbalance.
- Immature angiogenesis (VEGF/HIF-1α) and dysregulated fibrinolysis (tPA, uPA) contribute to recurrence.
- Membrane characteristics, systemic inflammation, imaging, and CSF dynamics impact recurrence risk.
Conclusions:
- cSDH recurrence indicates failed inflammatory resolution and vascular maturation, not just incomplete surgical removal.
- Integrating biomarkers and imaging may allow risk stratification and personalized therapies to prevent recurrence.
Related Concept Videos
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...